 |
Eric R. Secor Jr., N.D., M.S., L.Ac.,
Dipl. Ac. (NCCAOM)
Assistant Professor
Department of Immunology
Center for Integrative Immunology and Vaccine Research
|
Professional Background
Dr. Eric Secor received his bachelors and pre-medical
training at Central Connecticut State University, and his N.D.
and M.S. from Bastyr University. While completing the doctoral
and masters program at Bastyr University in Seattle, Washington,
Dr. Secor specialized in integrative medicine and nutritional
supplement education. His integrated experience includes clinic
rounds in an HIV Integrated Care Clinic, Mind Body Clinic,
Combined Natural Medicine and Acupuncture Clinic, a year
experience in counseling, and advanced studies in The Kür Spa
Course: Balneology and Health Resort Medicine in the Czech
Republic, where he continues to consult with patient programs.
He has worked and consulted for the nutriceutical industry since
1995. He successfully completed a postdoctoral fellowship with a
concentration in immunology from the National Institutes of
Health (NIH) and just received a five year K-08 Career
Development Award from NIH/NCCAM.
His
current studies in the laboratory of Dr. Roger Thrall at the
University of Connecticut Health Center in Farmington include:
the anti-inflammatory effects of botanical extracts such as Bromelain from Ananas cosmosus (common pineapple), the use of
complementary medicine in clinical setting, completion of the
Masters of Public Health degree, and postdoctoral course-work
in immunology.
[ back to top ]
Bromelain Research and Allergic Asthma
Bromelain is a water-soluble extract from the stems of Ananas
comosus, the pineapple plant, and has been used clinically as an
anti-inflammatory agent by alternative medicine practitioners
for decades.
Clinically, oral administration of Bromelain has been used as
adjunctive treatment in conditions such as: rheumatoid
arthritis, soft tissue injuries, and chronic pain. We have
previously demonstrated that Bromelain, a natural product
extracted from the stems of pineapple, exerts anti-inflammatory
and immuno-modulatory effects in an ovalbumin (OVA)-induced
mouse model of allergic airway disease (AAD). Bromelain (Br)
treatment decreased CD4+ T cells, eosinophils and Th2 cytokines
in the bronchoalveolar lavage (BAL) during AAD.
(Secor et. al.,
Oral Bromelain Attenuates
Inflammation in an Ovalbumin-induced Murine Model of Asthma, 2007
Cellular Immunology 237:68-75)
Our preliminary data demonstrate that Br reduced cell surface
CD25 expression and intracellular Stat5 expression in CD4+ T
cells. CD25 and Stat5 are components of IL-2 signaling which is
required for activation, proliferation, and survival of T cells.
The reduction in CD25 and Stat5 expression by Br may be due to
direct effects on IL-2 signaling, or it may occur indirectly
through secondary action on antigen presenting cells (APCs). In
support of this, new preliminary data has been presented showing
that Br treatment decreases MHC-II on dendritic cells, which
would limit the activation of CD4+ T cells.
[ back to top ]
Recent Research Presentations and Publications
Secor Jr.
ER. 2003. Nutritional supplements in the orthopedic
patient: Current environment and considerations for
management. Techniques in Orthopaedics 18:62-66.
Markow MJ, Secor Jr. ER. 2003. Acupuncture for the pain
management of osteoarthritis of the knee.
Techniques in Orthopaedics 18:33-36.
Secor Jr. ER, Blumberg JH, Markow MJ, MacKenzie J,
Thrall RS. 2004. Implementation of outcome measures in a
complementary and alternative medicine clinic: evidence
of decreased pain and improved quality of life.
J Alt Comp Med 10:506-513.
Secor Jr. ER, Carson IV, WF, Cloutier MM, Guernsey LA,
Schramm CM, Wu CA, Thrall RS. 2005. Bromelain exerts
anti-inflammatory effects in an ovalbumin-induced murine
model of allergic airway disease.
Cell Immunology 237:68-75.
Schramm CM, Guernsey L, Secor E, Thrall RS. 2006.
Tolerance induced by chronic inhaled antigen in a murine
asthma
model is not mediated by endotoxin. Biochim Biophys Acta
1762:499-501.
Kabbur PM, Carson IV, WF, Guernsey LA, Secor Jr. ER,
Thrall RS, Schramm CM. 2006. Interleukin-10 does not
mediate inhalational tolerance in a chronic model of
ovalbumin-induced allergic airway disease.
Cell Immunology 239:67-74
Secor Jr. ER, Carson IV, WF, Singh A, Pensa M, Guernsey
LA, Schramm CM, Thrall RS. 2007. Oral bromelain
attenuates inflammation in an ovalbumin-induced murine
model of asthma: eCAM online-link:
http://ecam.oxfordjournals.org/cgi/content/abstract/nel110v1
Secor Jr. ER, Singh A, Guernsey LA, Schramm CM Thrall
RS. 2007. Modulation of CD25 dependant T cell
activation by bromelain. eCAM (Accepted for Rapid
Communication).
Singh A, Carson IV, WF, Secor Jr. ER, Guernsey LA,
Flavell RA, Clark RB, Thrall RS, Schramm CM.
2007. Regulatory role of B cells in a murine model of
allergic airway disease.
J Immunol (Pending revisions).
Carson IV, WF, Guernsey LA, Singh A, Secor Jr. ER,
Wohlfert EA, Schramm CM, Clark RB, Thrall RS.
2007. Cbl-b deficiency results in exacerbation of acute
inflammation and inhibits the spontaneous resolution of
disease in the chronic stages of an ovalbumin-induced
model of allergic airway disease in mice. Am J Pathol (Submitted for Publication).
Singh A, Thrall RS, Guernsey LA, Carson IV, WF, Secor
Jr. ER, Chattopadhyay S, Cone R, Rajan TV, Schramm CM.
2007. Subcutaneous late phase responses are augmented
during local inhalational tolerance in a murine asthma
model. J Allergy Clin Immunol (Submitted for
Publication).
Thirunavukkarasu M, Pant R, Zhan L, Varma Penumathsa S,
Secor Jr. ER, Otani H, Thrall RS, Maulik N. 2007.
Bromelain induces cardioprotection against ischemia
reperfusion injury through Akt/Foxo Pathway in rat
myocardium. Am J Physiol Heart Circ Physiol (Submitted
for Publication).
[ back to top ]
Abstract Presentations
2006
Secor Jr. ER, Pensa M, Singh A, Carson IV, WF, Guernsey
LA, Thrall, RS. (May) Oral bromelain treatment reduces
airway inflammation in an ovalbumin-induced model of
allergic airway disease. North American Research
Conference on Complementary and Integrative Medicine.
Edmonton, AB, Canada.
Secor Jr. ER, Singh A, Carson IV, WF, Guernsey LA,
Thrall RS. (Aug) Bromelain treatment reduces IL-6 and
TNF-a levels in a murine model of acute allergic airway
disease. 21th Annual American Association of
Naturopathic Medicine Conference. Portland, OR.
Singh A, Carson IV,WF, Secor Jr. ER, Guernsey LA,
Schramm CM, Thrall RS. (May) Role of B cells as antigen
presenting cells in the development of an ovalbumin
induced murine model of asthma. American Association
of Immunologists Annual Conference. Boston, MA.
2007
Singh A, Carson IV,WF, Secor Jr. ER, Guernsey LA,
Flavell RA, Clark RB, Thrall RS, Schramm CM (May).
Adoptive transfer of hilar lymph node B cells inhibits
allergic airway disease via induction of CD4+ CD25+Foxp3+ T cells. American Thoracic Society International
Conference. San Francisco, CA.
McNamara JT, Carson IV,WF, Guernsey LA, Secor Jr. ER,
Singh A, Schramm CM, Thrall RS (April). Regional
increases of CD103+ Tregs corresponds with resolution of
murine allergic airway disease.
J. Immunol.178: 39.10.
Secor Jr. ER, Blumberg JH, Markow MJ, MacKenzie J,
Thrall RS (Nov). Chiropractic care: Evidence of efficacy
through practice-based outcomes research, American
Public Health Association Annual Meeting,
Washington, DC. (Accepted for Poster Presentation).
Secor Jr. ER, Singh A, Guernsey LA, Schramm CM, Thrall
RS (Oct). Modulation of CD25 dependant T cell activation
by Bromelain. European Traditional Medicine 2007
International Congress Vinci, Italy (Accepted for Oral
Presentation).
[ back to top ]
Mentored Student Presentations
2005
Babcock, Joe. The protease bromelain cleaves the antigen
ovalbumin in vitro but not in-vivo. State of North
Carolina Undergraduate Research Day, Undergraduate
Student, Duke University, Raleigh, NC.
2006
Pensa, Mellisa. The effect of oral bromelain treatment
in an ovalbumin-induced model of allergic airway
disease. Graduate Student Research Day, Medical Student,
University of Connecticut Health Center, Farmington, CT.
Reiss, Alexander. The effect of bromelain treatment on
regulatory T cells in a murine model of allergic airway
disease. College Fellowship Poster Session,
Undergraduate Student, University of CT, Storrs, CT.
[ back to top ]
|
Contact Information
Eric R. Secor Jr., N.D., M.S.,
L.Ac., Dipl. Ac. (NCCAOM)
University of Connecticut Health Center
263 Farmington Avenue
Farmington, CT 06030
Phone: 860-679-8439
Fax: 860-679-1868
Email: esecor@uchc.edu
Helpful Links
|